Avenue Therapeutics, Inc. announced that Ms. Garrett Ingram has been appointed to its Board of Directors. Ms. Ingram joined Cipla USA, Inc. in July 2019 as Chief Commercial Officer, Specialty Hospital Business, U.S. to lead the transformation of the current and future specialty branded platforms. She will serve as one of the three Cipla representatives on Avenue's Board of Directors, succeeding Mr. Nishant Saxena who has stepped down from Avenue's Board of Directors to become Cipla's Chief Executive Officer of International Business (Europe and Emerging Markets). Prior to her new role at Cipla, Ms. Ingram served as Chief Marketing Officer at MannKind Corporation, based in California.